For instance, AMI patients with Gal-3 levels above the 75th percentile have a markedly increased risk of death, HF development, and HF hospitalization within the first year compared to those below the median (O'Donoghue et al., 2016; Kusaka et al., 2015). The gene discussed is LGALS3; the disease is hydrops fetalis.